Comparative Effectiveness And Personalized Medicine: Evolving Together Or Apart?

被引:13
|
作者
Epstein, Robert [1 ]
Teagarden, J. Russell [1 ]
机构
[1] Medco Hlth Solut, Medco Res Inst, Franklin Lakes, NJ USA
关键词
PROTON PUMP INHIBITORS; CLOPIDOGREL; PHARMACOGENETICS; WARFARIN; DETERMINANTS; POLYMORPHISM; VKORC1; IMPACT; CARE;
D O I
10.1377/hlthaff.2010.0642
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Comparative effectiveness research and personalized medicine can at first appear to be at odds with each other. This research initially compares the overall benefits of one therapeutic approach with those of another for the majority of patients, while personalized medicine identifies the subsets of patients who could benefit based on personal characteristics such as genetics. But because comparative effectiveness research typically enrolls heterogeneous patient populations, it can uncover subpopulations that might benefit most from particular treatments. Thus, comparative effectiveness research can help discern the appropriate role of personalized medicine in improving health care outcomes and rationalizing costs.
引用
收藏
页码:1783 / 1787
页数:5
相关论文
共 50 条
  • [1] Comparative effectiveness research and genomic personalized medicine
    Lyman, Gary H.
    Hirsch, Bradford
    [J]. PERSONALIZED MEDICINE, 2010, 7 (03) : 223 - 227
  • [2] Comparative Effectiveness, Personalized Medicine and InnovationThe Path Forward
    Adrian Thomas
    Audrey Phillips
    Robert Donnelly
    Catherine Tak Piech
    [J]. PharmacoEconomics, 2010, 28 : 923 - 930
  • [3] Comparative Effectiveness Research and Personalized Medicine Catalyzing or Colliding?
    Epstein, Robert S.
    Teagarden, J. Russell
    [J]. PHARMACOECONOMICS, 2010, 28 (10) : 905 - 913
  • [4] Comparative Effectiveness, Personalized Medicine and Innovation The Path Forward
    Thomas, Adrian
    Phillips, Audrey
    Donnelly, Robert
    Piech, Catherine Tak
    [J]. PHARMACOECONOMICS, 2010, 28 (10) : 923 - 930
  • [5] Personalized medicine and comparative effectiveness research in an era of fixed budgets
    Brown P.M.
    [J]. EPMA Journal, 2010, 1 (4): : 633 - 640
  • [6] Does Comparative-Effectiveness Research Threaten Personalized Medicine?.
    Garber, Alan M.
    Tunis, Sean R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (19): : 1925 - 1927
  • [7] Evolving Paradigms of Personalized Medicine in Oncology
    Dhingra, Kapil
    [J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2017, 30 (06): : 305 - 308
  • [8] Dancing together apart/Dancing apart together
    Roy, Sanjoy
    [J]. DANCING TIMES, 2016, 106 (1267): : 70 - 71
  • [9] Comparative Effectiveness in Personalized Medicine Clearly Defining the Intended Use Population
    Hornberger, John C.
    [J]. VALUE IN HEALTH, 2013, 16 (04) : 696 - 696
  • [10] Evolving together, evolving apart: measuring the fitness of rhizobial bacteria in and out of symbiosis with leguminous plants
    Burghardt, Liana T.
    [J]. NEW PHYTOLOGIST, 2020, 228 (01) : 28 - 34